Related Experiment Video

Updated: May 28, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Update on the medical treatment of stable angina

Jean-Louis Gayet1, Franck Paganelli, Alain Cohen-Solal

  • 1Colombes, France. jeanlouisgayet@aol.com

Archives of Cardiovascular Diseases
|November 3, 2011
PubMed

Insights

Stable angina treatment involves lifestyle changes and medications like statins and aspirin. Newer drugs offer improved efficacy for managing coronary artery disease and preventing cardiovascular events, though side effects require careful consideration.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Stable angina is a manifestation of coronary artery disease.
  • Effective management is crucial to prevent acute attacks and long-term cardiovascular events.
  • Treatment strategies include lifestyle modifications, diet, and pharmacological interventions.

Purpose of the Study:

  • To review current pharmacological treatments for stable angina.
  • To evaluate the efficacy and evidence levels of various antianginal medications.
  • To highlight the importance of considering patient factors like age and comorbidities.

Main Methods:

  • Literature review of pharmacological treatments for stable angina.
  • Analysis of evidence supporting different drug classes, including traditional and novel agents.
  • Consideration of drug efficacy, side effect profiles, and patient populations.

Main Results:

  • Statins and aspirin are foundational for coronary artery disease prevention.
  • Beta-blockers and ACE inhibitors show efficacy in specific contexts like post-MI and heart failure.
  • Newer agents like trimetazidine, ivabradine, and nicorandil offer alternative mechanisms, with ranolazine recently approved.
  • Evidence for efficacy varies, generally stronger for newer medications.

Conclusions:

  • Pharmacological treatment is essential for stable angina, complementing lifestyle changes.
  • A range of medications, from traditional to novel, are available, each with varying efficacy and side effect profiles.
  • Careful patient selection and monitoring are necessary, especially in elderly and polymedicated individuals.

More Related Videos

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...